PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers

Current studies aiming at identifying single immune markers with prognostic value have limitations in the context of complex antitumor immunity and cancer immune evasion. Here, we show how the integration of several immune markers influences the predictions of prognosis of gastric cancer (GC) patien...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Main Authors: Ying, Le, Yan, Feng, Meng, Qiaohong, Yu, Liang, Yuan, Xiangliang, Gantier, Michael P., Williams, Bryan R. G., Chan, David W., Shi, Liyun, Tu, Yugang, Ni, Peihua, Wang, Xuefeng, Chen, Weisan, Zang, Xingxing, Xu, Dakang, Hu, Yiqun
Formato: Artigo
Idioma:Inglês
Publicado: Taylor & Francis 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980489/
https://ncbi.nlm.nih.gov/pubmed/29872566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1433520
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares